Q&A: AdvaMed Accel's Shadan, Wittorf Outline Lobbying Priorities, More

In a podcast exclusive with Medtech Insight, the new chair and executive director of small-company-focused AdvaMed Accel discussed their priorities for supporting small medtech companies. Among the topics discussed were the medical device tax, reimbursement uncertainty and empowering women in the industry.

Exclusive interview Q&A KOI

Martha Shadan, the new chair of AdvaMed Accel, and its executive director, Ashley Wittorf, recently sat down with Medtech Insight to discuss their lobbying priorities for small medtech companies. The two outlined their strategic goals to fight the medical device excise, reform the reimbursement processes and advocate for women in leadership positions in the medtech sector. (Also see "Shadan Brings Multi-Perspective View Of Medtech To AdvaMed Accel Chair Post" - Medtech Insight, 10 May, 2018.)

Listen to our interview in the player below and read a transcript of the Q&A:

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Leadership

Handheld Diagnostics: A Resurging Category That is Here to Stay

 

Handheld diagnostics are more powerful, accessible and clinically relevant than ever. Medtech Insight spoke to companies behind such technologies to learn how they work and discuss their commercial models.

Execs On The Move: 12-23 May 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

German Bionic Launches ‘Strongest Exoskeleton To Date’

 

German Bionic’s new exoskeleton Exia helps healthcare practitioners, nurses, and other caregivers to lift and move patients by supporting muscle movement and reducing the risk of injury.

Execs On The Move: 5-9 May 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

More from Medtech Insight

Roche Diagnostics Day 2025: ‘We Need To Become A Leader In Decentralized Testing’

 

Roche aims to grow its diagnostics sales by mid to high single digits, said CEO of Roche Diagnostics Matt Sause. The company unveiled the Axelios synthesis and sequencing solution and discussed its “long-term commitment” to China, as well as its business strategy for the next five years.

BD To Shift China-Facing Production, Ramp Up US Output With $2.5B To Counter Tariff Blow

 
• By 

BD is accelerating transitions of product sourcing for China to avoid tariffs. Historically, products like Vacutainer were exported from Sumter, SC, to China, and Flush was shipped from Columbus, NE.

Zika Virus Test Among 4 New FDA Device Classifications

 
• By 

The FDA plans to announce class II status for four new device types, including tests for the Zika virus and genetic condition Fragile X. This follows earlier announcements and highlights a trend toward diagnostic classifications. The classifications are considered deregulatory, meaning they will hel